High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation. [electronic resource]
Producer: 20030728Description: 267-71 p. digitalISSN:- 0268-3369
- Adult
- Antigens, CD34
- Antilymphocyte Serum -- administration & dosage
- CD3 Complex
- Cell Count
- Cyclophosphamide -- administration & dosage
- Female
- Follow-Up Studies
- Graft Survival
- Hematologic Neoplasms -- mortality
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Lymphocyte Depletion
- Male
- Middle Aged
- Pilot Projects
- Transplantation Conditioning -- methods
- Transplantation, Homologous -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.